334 replies to this topic

[ImmInst]

3 Reasons Behind Geron Corporation (GERN)'s Rebound
Next iPhone News - 1 hour ago

In October 2013, Geron sold its entire embryonic stem cell pipeline to BioTime, Inc. (NYSEMKT:BTX)'s new subsidiary Asterias Biotherapeutics, in exchange for a 21.4% stake in Asterias and undisclosed royalties on commercialized treatments ...

View the full article

[ImmInst]

Is Geron Corporation (GERN) Finally Onto Something?
Next iPhone News - Dec 17, 2013

Geron Corporation (NASDAQ:GERN) has continued reshaping itself this year by closing a deal to sell its human embryonic stem cell assets to BioTime, Inc. (NYSEMKT:BTX), and closing its research facility in California last April. To save money, Geron ...

View the full article

[ImmInst]

Geron Corporation (GERN): New Analyst Report from Zacks Equity Research ...
NASDAQ - 57 minutes ago

GRN1005, which became a part of Geron's pipeline under an agreement with Angiochem, Inc., was being studied for the treatment of cancers in the brain.

View the full article

[ImmInst]

Healthcare Unusual volume: Natural Alternatives International (NASDAQ:NAII ...
Gaining Green - 1 hour ago

BioTime, Inc. (NYSEMKT:BTX), through its new research products division ESI BIO, unveiled a new responsive design website, www.

View the full article

[ImmInst]

Geron sells last drug in pipeline to J&J unit
Yahoo News - 2 hours ago

Under the deal, J&J's unit Janssen Biotech Inc, will be responsible for the development, regulatory approval and sales of the cancer compound, imetelstat, worldwide.

View the full article